Nexmezol (Esomeprazole)

Esomeprazole, the active ingredient in Nexmezol, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, and prevention of NSAID‑induced gastric ulcers.

GNH USA supplies Nexmezol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Nexmezol, a proton pump inhibitor, is employed to manage acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: heals mucosal damage and maintains acid control. - NSAID‑induced gastric ulcer prevention: reduces the risk of ulcer formation in patients receiving NSAIDs. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with appropriate antibiotics.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort. - Flatulence: gas accumulation. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, angioedema): require immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Hypomagnesemia: low magnesium levels with prolonged use. - Elevated liver enzymes: monitor hepatic function. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: rare but life‑threatening skin reactions.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in severe impairment. - Review concomitant medications: avoid known contraindicated drugs. - Monitor magnesium levels: especially during long‑term treatment. - Use caution in pregnancy: weigh benefits against potential risks. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Esomeprazole may affect the absorption or metabolism of other medicines.

Major Interactions (Avoid): - Ketoconazole, atazanavir, nelfinavir: require acidic environment for absorption. - Clopidogrel: reduced activation leading to decreased antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR, monitor coagulation. - Digoxin: increased serum concentrations, watch for toxicity. - Methotrexate: reduced clearance, monitor renal function and levels.